NHS increases access to improved breast cancer test

6 February 2015

A test able to predict the likely success of chemotherapy and the risk of recurrence will be widely available in England from April 2015.

NHS hospital trusts will be able to sign up to an access scheme from April 2015 to offer a multi-gene Oncotype DX test designed to reduce over-treatment and unnecessary costs for the healthcare system.

"The improved access to a test that allows for a better understanding of individual tumour biology is an important step forward to personalised care for UK breast cancer patients," said Nigel Bundred, professor in surgical oncology at the University Hospital of South Manchester NHS Foundation Trust.

"Having this knowledge can give us greater confidence in recommending a treatment plan best suited for an individual patient that decreases the complications of treatment without compromising survival."



Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.